N-methyl-D-aspartate receptor (NMDAr) antagonists such as ketamine (KET) produce psychotic-like behavior in both humans and animal models. NMDAr hypofunction affects normal oscillatory dynamics and synaptic plasticity in key brain regions related to schizophrenia, particularly in the hippocampus and the prefrontal cortex. It has been shown that prior long-term potentiation (LTP) occluded the increase of synaptic efficacy in the hippocampus-prefrontal cortex pathway induced by MK-801, a noncompetitive NMDAr antagonist. However, it is not clear whether LTP could also modulate aberrant oscillations and short-term plasticity disruptions induced by NMDAr antagonists. Thus, we tested whether LTP could mitigate the electrophysiological changes promoted by KET. We recorded HPC-PFC local field potentials and evoked responses in urethane anesthetized rats, before and after KET administration, preceded or not by LTP induction. Our results show that KET promotes an aberrant delta-high-gamma cross-frequency coupling in the PFC and an enhancement in HPC-PFC evoked responses. LTP induction prior to KET attenuates changes in synaptic efficiency and prevents the increase in cortical gamma amplitude comodulation. These findings are consistent with evidence that increased efficiency of glutamatergic receptors attenuates cognitive impairment in animal models of psychosis. Therefore, high-frequency stimulation in HPC may be a useful tool to better understand how to prevent NMDAr hypofunction effects on synaptic plasticity and oscillatory coordination in corticolimbic circuits. The hippocampal-prefrontal cortex (HPC-PFC) monosynaptic pathway is implicated in cognitive functions, such as working memory, decision making, and spatial-temporal processing 1,2. Dysfunctional connectivity within HPC-PFC circuits is associated with the pathophysiology and genetic predisposition to schizophrenia 3-5. In schizophrenia, HPC-PFC connectivity is decreased during working memory tasks and increased in resting state 5-7. Such effects may be mediated, at least in part, by N-methyl-D-aspartate receptor (NMDAr). NMDAr binding is reduced in schizophrenic patients in both HPC and PFC, and administration of an NMDAr antagonist, such as ketamine, can induce psychotic symptoms in healthy patients and an increase in resting-state HPC-PFC connectivity 8-10. This NMDAr hypofunction also affects synaptic plasticity, inducing impairments in critical circuits, such as HPC-PFC, promoting cognitive symptoms by pathological neural activity 11-13. However, the relationship between synaptic plasticity in HPC-PFC circuits and schizophrenia is not fully understood.